HLA-DQ在肾移植中的意义:重新评估HLA配型优先次序以改善移植结局
该专家综述指出,肾分配中HLA配型权重逐步降低,但慢性抗体介导排斥反应成为移植物丢失主因,常由针对供者HLA-DQ的从头抗体导致。作者建议重点研究供受者HLA II类尤其HLA-DQα1β1错配对移植结局的影响,并优化配型策略。
要点
- HLA配型权重降低后,针对供者HLA-DQ的从头抗体是慢性抗体介导排斥和移植失败的重要原因。
- 从头供者特异性HLA抗体增加致敏,影响再次移植的等待名单准入。
- 需重点研究供受者HLA-DQα1β1错配,改进数据收集和模拟方法以减少不平等。
核心结论
- 降低HLA配型权重的政策可能导致移植物丢失增加、经济负担加重和长期健康后果,尤其因HLA-DQ错配引发的慢性抗体介导排斥反应。
研究设计与样本
- 专家综述与建议,基于现有证据讨论肾分配中HLA配型政策的影响,并提出研究方向。
主要发现
- 慢性抗体介导排斥反应是移植物丢失的主要原因,常由针对供者HLA-DQ的从头抗体介导。
- 从头供者特异性HLA抗体增加致敏,影响再次移植的等待名单准入。
临床怎么用
- 建议重新评估供受者HLA II类尤其HLA-DQα1β1错配的影响,收集适当数据并应用模拟方法优化配型策略。
局限性
- 本文为专家综述,未提供原始研究数据或定量分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The weight of human leukocyte antigen (HLA) matching in kidney allocation algorithms, especially in the United States, has been devalued in a stepwise manner, supported by the introduction of modern immunosuppression. The intent was further to reduce the observed ethnic/racial disparity, as data emerged associating HLA matching with decreased access to transplantation for African American patients. In recent years, it has been increasingly recognized that a leading cause of graft loss is chronic antibody-mediated rejection, attributed to the development of de novo antibodies against mismatched donor HLA expressed on the graft. These antibodies are most frequently against donor HLA-DQ molecules. Beyond their impact on graft survival, generation of de novo donor-specific HLA antibodies also leads to increased sensitization, as measured by panel-reactive antibody metrics. Consequently, access to transplantation for patients returning to the waitlist in need of a second transplant is compromised. Herein, we address the implications of reduced HLA matching policies in kidney allocation. We highlight the observed diminished outcome data, the significant financial burden, the long-term health consequences, and, more important, the unintended consequences. We further provide recommendations to examine the impact of donor-recipient HLA class II and specifically HLA-DQα1β1 mismatching, focusing on collection of appropriate data, application of creative simulation approaches, and reconsideration of best practices to reduce inequalities while optimizing patient outcomes.
引用
- Tambur AR, Kosmoliaptsis V, Claas FHJ, et al. Significance of HLA-DQ in kidney transplantation: time to reevaluate human leukocyte antigen-matching priorities to improve transplant outcomes? An expert review and recommendations. Kidney Int. 2021. PMID: 34246656. doi:10.1016/j.kint.2021.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。